Kimberly-Clark’s 54-Year Dividend Streak Faces Pressure as Free Cash Flow Barely Covers Payout
Kimberly-Clark has raised its dividend for over five decades, but a looming $48 billion acquisition and razor-thin cash flow coverage are putting that streak under pressure most income investors haven't noticed yet.
Kimberly-Clark (NASDAQ:KMB | KMB Price Prediction) paid its third straight $1.28 quarterly dividend on October 2, 2026. The company says the raise behind that check extended its run to 54 consecutive years of increases. The payout records support that claim as far back as they go. The quarterly rate has gone up every year since 1999, climbing from $0.26 to $1.28. Retirees who own the stock need to know whether there is still enough cash behind the check.
Free Cash Flow Barely Covers the Payout
At $97.91, the $5.12 forward dividend works out to a yield of roughly 5.2%. The coverage is lower than that yield suggests. In 2025, operating cash flow fell to $2.777 billion and capex rose to $1.138 billion, which left free cash flow at $1.639 billion. Dividends cost $1.660 billion, or about 101% of free cash flow.
The first half of 2026 was a little better. Free cash flow came to $877 million, and dividends used up about 96% of it. Against adjusted 2025 EPS of $7.53, the payout ratio is about 68%. Against trailing GAAP EPS of $5.07, it rises to about 101%.
Pending Acquisition Arrives With Little Balance Sheet Cushion
Kimberly-Clark carries total liabilities of $16.680 billion against shareholders’ equity of only $1.874 billion. The company has been protecting the dividend by cutting buybacks. Repurchases dropped to $141 million in 2025 from $1 billion in 2024. On top of that is the roughly $48.7 billion purchase of Kenvue (NYSE:KVUE). Chief Executive Mike Hsu sounds confident:
“Our pending acquisition of Kenvue remains on track to close by the end of this year. In sum, our vision for a new kind of health and wellness company, reimagined care for billions of people around the world, and lasting value for shareholders is becoming clearer by the day.”
On the August call, management added: “The closer we look at this thing, the better it gets.”
Pricing Power Is Being Tested
Second-quarter adjusted EPS of $2.12 came in above the $2.006 consensus. Revenue of $4.189 billion missed expectations, though. Part of the margin story was temporary: a $45 million tariff refund helped lift gross margin to 38.8%. Category growth in North America slowed from 3.7% to 1.9%. Management also expects about $150 million in second-half input-cost pressures and only low single digit price increases.
“Our team is executing with agility and addressing discrete headwinds that will moderate our growth and earnings potential in 2026.”
Guidance now calls for adjusted EPS attributable to Kimberly-Clark to show a low-single-digit decline in constant currency.
How the Peers Compare
| Company | Dividend Yield | Trailing P/E | Beta |
|---|---|---|---|
| Kimberly-Clark | 5.21% | 19x | 0.275 |
| Procter & Gamble (NYSE:PG) | 2.82% | 23x | 0.377 |
| Colgate-Palmolive (NYSE:CL) | 2.37% | 35x | 0.322 |
Procter & Gamble pays out about 64% of trailing earnings. Colgate-Palmolive pays out about 82%. Kimberly-Clark’s higher yield likely reflects, in part, its thinner coverage.
Verdict: The Dividend Holds, With Less Room for Error
The dividend looks secure so far. The company sells essential products, has delivered 10 consecutive quarters of volume-plus-mix growth, and has five decades of raises at stake. Management has strong incentive to protect the streak, and increases may stay small while Kenvue is being integrated. Free cash flow covering the payout only about one to one means Kimberly-Clark has thinner coverage than its peers. Procter & Gamble has the widest margin of the three. Income investors who own Kimberly-Clark are collecting a reliable 5% yield that comes with more risk than the stock’s reputation suggests (we ranked ten of the longest-running Dividend Kings by valuation in a free report you can grab here).
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
